Skip to main content

Table 4 The novel pathogenic phenotypically enriched locus

From: Systematic identification of phenotypically enriched loci using a patient network of genomic disorders

PEL ID

Type*

Chr

Start

Length (Kb)

Phenotype

Cases/Carrier (DGV)

P valuea

P b

PEL 3

d

3

181296306

175.931

Anophthalmia

6/9 (0)

1.80E-15

100

PEL 5

d

7

95693340

89.973

Ectrodactyly

7/10 (0)

1.70E-14

100

PEL 4

d

3

181296306

175.931

Abnormality of globe size

8/9 (0)

1.90E-14

100

PEL 4

d

3

181296306

175.931

Aplasia/Hypoplasia affecting the eye

8/9 (0)

1.90E-13

100

PEL 71

d

2

200208169

38.268

Abnormality of the palate

11/19 (0)

2.10E-11

100

PEL 31

d

3

181166306

576

Abnormality of globe size

6/9 (0)

4.10E-11

100

PEL 105

d

2

200208169

38.268

Abnormality of the oral cavity

12/19 (0)

2.50E-10

100

PEL 84

d

15

100019051

189.992

Growth delay

13/18 (0)

2.70E-10

100

PEL 31

d

3

181166306

576

Aplasia/Hypoplasia affecting the eye

6/9 (0)

2.70E-10

100

PEL 128

d

2

200208169

38.268

Abnormality of the mouth

14/19 (0)

1.90E-09

100

PEL 131

d

15

100019051

189.992

Growth abnormality

14/18 (0)

6.40E-09

100

PEL 129

d

15

99057570

65.959

Growth delay

11/16 (0)

8.10E-09

100

PEL 69

d

11

31735689

39.768

Aplasia/Hypoplasia affecting the eye

5/8 (0)

1.00E-08

100

PEL 126

d

2

166091754

49.616

Seizures

10/15 (0)

1.00E-08

100

PEL 175

d

7

112349829

160.71

Delayed speech and language development

12/18 (0)

1.00E-08

100

PEL 78

d

14

29904720

411.94

Aplasia/Hypoplasia of the cerebrum

10/12 (0)

1.50E-08

100

PEL 82

d

14

29904720

411.94

Aplasia/Hypoplasia of the cerebrum

10/12 (0)

1.50E-08

100

PEL 141

d

7

114297499

533.997

Delayed speech and language development

11/15 (0)

4.50E-08

100

PEL 166

d

2

166244769

311.476

Seizures

9/14 (0)

6.00E-08

100

PEL 202

d

15

99057570

65.959

Growth abnormality

12/16 (0)

8.80E-08

100

PEL 152

d

14

29904720

411.94

Microcephaly

8/12 (0)

1.60E-07

100

PEL 159

d

14

29904720

411.94

Microcephaly

8/12 (0)

1.60E-07

100

PEL 216

d

2

200208169

38.268

Abnormality of the palate

7/13 (0)

1.60E-07

100

PEL 385

d

2

200246437

0

Abnormality of the face

16/19 (0)

1.60E-07

100

PEL 137

d

6

76509712

359.49

Joint laxity

5/9 (0)

1.60E-07

100

PEL 390

d

7

112349829

160.71

Neurodevelopmental delay

13/18 (0)

1.60E-07

100

PEL 412

d

13

92065689

29.285

Growth delay

9/17 (0)

2.00E-07

100

PEL 419

d

13

92065689

29.285

Growth delay

9/17 (0)

2.00E-07

100

PEL 436

D

16

3831263

32.469

Abnormality of the face

15/18 (0)

4.20E-07

100

PEL 222

d

2

201936560

57.623

Abnormality of the mouth

10/13 (0)

4.80E-07

100

PEL 222

d

2

200208169

38.268

Abnormality of the mouth

10/13 (0)

4.80E-07

100

PEL 242

d

7

114297499

533.997

Neurodevelopmental delay

12/15 (0)

5.20E-07

100

PEL 114

d

13

48557360

146.432

Abnormality of the globe

8/9 (0)

5.90E-07

100

PEL 250

d

7

119973023

238.728

Delayed speech and language development

9/13 (0)

8.80E-07

100

PEL 123

d

12

66224830

22.517

Short stature

7/8 (0)

1.10E-06

100

PEL 184

d

1

28743173

21.263

Deeply set eye

4/7 (0)

1.90E-06

100

PEL 462

d

1

11270844

47.828

Abnormality of the skull

10/14 (0)

1.90E-06

100

PEL 417

d

2

201936560

57.623

Abnormality of the mouth

9/13 (0)

2.00E-06

100

PEL 330

d

14

29781404

230.359

Seizures

7/12 (0)

2.10E-06

100

PEL 227

d

9

77206264

34.573

Seizures

7/10 (0)

2.10E-06

100

PEL 133

D

2

219965169

9.153

Cutaneous finger syndactyly

3/5 (0)

2.30E-06

100

PEL 116

d

3

181296306

6.681

Abnormality of the ocular region

9/9 (0)

2.50E-06

100

PEL 173

D

2

59105866

181.965

Midface retrusion

3/5 (0)

4.00E-06

100

PEL 120

D

2

59105866

181.965

Strabismus

5/5 (0)

4.40E-06

100

PEL 276

d

7

94174003

41.631

Decreased body weight

4/7 (0)

7.20E-06

100

PEL 329

d

7

95693340

89.973

Abnormality of limb bone morphology

8/10 (0)

1.30E-05

100

PEL 304

d

X

133530468

102.522

Global developmental delay

6/8 (0)

1.50E-05

100

PEL 388

d

10

28842276

86.821

Abnormality of the eyelid

6/8 (0)

1.70E-05

100

PEL 210

D

2

59105866

181.965

Feeding difficulties in infancy

4/5 (0)

1.70E-05

100

PEL 455

d

10

28842276

86.821

Abnormality of the palpebral fissures

5/8 (0)

2.00E-05

100

PEL 251

d

13

41726952

39.763

Abnormal eye morphology

6/7 (0)

2.00E-05

100

PEL 470

d

10

28842276

86.821

Abnormality of the hair

5/8 (0)

2.20E-05

100

PEL 358

d

1

28743173

21.263

Abnormality of globe location

5/7 (0)

2.90E-05

100

PEL 460

d

3

181648378

93.928

Abnormality of the ocular region

7/9 (0)

3.60E-05

100

PEL 338

d

5

170676605

370.857

Abnormality of the cardiac septa

4/6 (0)

3.90E-05

100

PEL 133

D

2

219965169

9.153

Toe syndactyly

3/5 (0)

4.00E-05

100

PEL 454

d

1

177800358

362.172

Short stature

5/7 (0)

4.40E-05

100

PEL 369

d

14

57423809

185.438

Abnormality of the eye

7/8 (0)

4.50E-05

100

PEL 449

d

7

94174003

41.631

Abnormality of the foot

5/7 (0)

4.90E-05

100

PEL 294

d

1

157149743

12.346

Abnormal hair quantity

3/4 (0)

5.70E-05

100

PEL 213

d

1

157149743

12.346

Abnormality of the lip

4/4 (0)

5.70E-05

100

PEL 327

d

19

10640379

140.937

Abnormal genital system morphology

4/5 (0)

7.00E-05

100

PEL 448

d

14

58205713

144.654

Abnormality of the skull

7/8 (0)

8.00E-05

100

PEL 203

d

13

33963658

138.576

Abnormality of the neck

3/3 (0)

8.20E-05

100

PEL 423

d

3

181692255

50.051

Abnormality of the face

9/9 (0)

1.10E-04

100

PEL 324

d

7

94953990

5.573

Growth abnormality

6/6 (0)

2.20E-04

100

PEL 456

D

2

219965169

9.153

Abnormality of the lower limb

4/5 (0)

5.20E-04

100

PEL 361

D

7

106664270

182.398

Strabismus

3/3 (0)

5.40E-04

100

PEL 404

D

7

107527586

136.426

Abnormality of eye movement

3/3 (0)

8.20E-04

100

PEL 407

D

1

113036203

122.933

Abnormality of the palate

3/3 (0)

1.00E-03

100

  1. *Duplication (D) and deletion (d). a Adjusted P-values from the Fisher’s Exact test of the case–control analysis. b This table show only those PELs with a penetrance higher than 100 %. The penetrance was calculated as described by Cooper et al. [8, 28]